Jesse Mendelsohn

Jesse Mendelsohn, executive vice president at Model N, discusses the broader issues impacting drug prices.

Jesse Mendelsohn, executive vice president at Model N, explains the pros and cons of continuing to pursue DTC programs once the government-run program launches.

Jesse Mendelsohn, executive vice president at Model N, discusses how selling drugs directly to patients differs from traditional government programs.

Navigating technology and regulatory shifts in pharma revenue management.